Technologies for sampling abnormal cells in the oesophagus
Details
- Buyer
- NHS England
- Published
- 4 November 2025
- Submission
- 17 November 2025
- Source
- uk:atamis:dhsc
Tender description
Preliminary market consultation to inform NHS Commercial Strategy for technologies that sample abnormal cells in the oesophagus.
Timeline
- Completed: Tender published4 November 2025Current notice
- Completed: Submission date17 November 2025
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Much of this procurement flows through framework agreements and the Crown Commercial Service. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
Clinical services are commissioned directly or through the Provider Selection Regime.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
Related buyers
Buyers similar to NHS England.
- 514£249.7m
- 438£15.3bn
- 414£111.6m
- 390£652.7m
- 327£25.1bn
- 296£1.6bn
- 291£1.3bn
- 284£3.1bn
- 154£121.9m
- 148£1.0bn
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.